-
1
المؤلفون: Qingqing Lin, Liping Mao, Li Shao, Li Zhu, Qingmei Han, Honghu Zhu, Jie Jin, Liangshun You
المصدر: Frontiers in Oncology
Frontiers in Oncology, Vol 10 (2020)مصطلحات موضوعية: Burden of disease, Cancer Research, medicine.medical_specialty, Younger age, lcsh:RC254-282, 03 medical and health sciences, 0302 clinical medicine, chronic myeloid leukemia, hemic and lymphatic diseases, death, Epidemiology, Health care, medicine, disability-adjusted life-years, 030212 general & internal medicine, Health policy, Original Research, business.industry, Mortality rate, Incidence (epidemiology), Myeloid leukemia, lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Oncology, 030220 oncology & carcinogenesis, incidence, epidemiology, business, Demography
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4d4de1cd529e874c8968b14e7c5d6725Test
https://pubmed.ncbi.nlm.nih.gov/33384954Test -
2
المؤلفون: Wanzhuo Xie, Jian Huang, Liangshun You, Hui Liu, Jueying Wei, Xiujin Ye, Wenbin Qian
المصدر: Oncotarget
مصطلحات موضوعية: 0301 basic medicine, Time Factors, Myeloid, Fusion Proteins, bcr-abl, Mice, SCID, Tyrosine-kinase inhibitor, T315I mutation, 0302 clinical medicine, hemic and lymphatic diseases, Antineoplastic Combined Chemotherapy Protocols, Tumor Cells, Cultured, Medicine, Enzyme Inhibitors, ABL, Hematology, Cell Death, biology, breakpoint cluster region, Myeloid leukemia, Drug Synergism, Proto-Oncogene Proteins c-mdm2, Tryptamines, Gene Expression Regulation, Neoplastic, medicine.anatomical_structure, Oncology, 030220 oncology & carcinogenesis, Imatinib Mesylate, Mdm2, Research Paper, medicine.drug, Proteasome Endopeptidase Complex, medicine.medical_specialty, medicine.drug_class, Antineoplastic Agents, 03 medical and health sciences, chronic myeloid leukemia, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Internal medicine, JNJ-26854165, Biomarkers, Tumor, Animals, Humans, Protein Kinase Inhibitors, neoplasms, BCR/ABL, Cell Proliferation, Dose-Response Relationship, Drug, business.industry, Imatinib, Xenograft Model Antitumor Assays, 030104 developmental biology, Drug Resistance, Neoplasm, Mutation, Proteolysis, Cancer research, biology.protein, Tumor Suppressor Protein p53, K562 Cells, business
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::eb3bff1c8668cb31d25ff81c02391c4cTest
https://doi.org/10.18632/oncotarget.13951Test